Skip to content

Programmed Intermittent Bolus During Continuous Interscalene Nerve Block for Shoulder Arthroplasty

Programmed Intermittent Bolus for Infusion of Local Anesthetic During Continuous Interscalene Nerve Blockade for Total Shoulder Arthroplasty: a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03268837
Enrollment
110
Registered
2017-08-31
Start date
2022-01-01
Completion date
2024-12-31
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Arthroplasty, Shoulder Osteoarthritis, Pain Management

Brief summary

A new infusion strategy named the 'programmed intermittent bolus' (PIB) technique delivers the hourly dose within minutes compared to the traditional infusion that delivers such dose over an hour. The PIB technique has demonstrated superior patient satisfaction and reduced local anesthetic consumption when utilized for pain control during labour and delivery. However, it is not known if the PIB technique gives any benefits during a continuous nerve block in other settings. The aim of this randomized controlled trial (RCT) is to elucidate if PIB is better than (traditional) continuous infusion for postoperative analgesia in patients receiving a continuous nerve block for total shoulder arthroplasty with respect to pain control.

Detailed description

Local anesthetics are often given in a continuous fashion to block specific nerves after an operation for pain control. A new infusion strategy named the 'programmed intermittent bolus' (PIB) technique delivers the hourly dose within minutes compared to the traditional infusion that delivers such dose over an hour. The PIB technique has demonstrated superior patient satisfaction and reduced local anesthetic consumption when utilized for pain control during labour and delivery. However, it is not known if the PIB technique gives any benefits during a continuous nerve block in other settings. The aim of this randomized controlled trial (RCT) is to elucidate if PIB is better than (traditional) continuous infusion for postoperative analgesia in patients receiving a continuous nerve block for total shoulder arthroplasty with respect to pain control.

Interventions

The Smith CADD(R)-Solis Ambulatory Infusion Pump will be used to provide programmed intermittent bolus for the interscalene block.

The Smith CADD(R)-Solis Ambulatory Infusion Pump will be used to provide continuous infusion for the interscalene block.

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients * American Society of Anesthesiologists (ASA) Physical Status I to III

Exclusion criteria

* Body mass index (BMI) \> 40 * Not able to communicate in ENglish * Unable to obtain consent * Infection over site of placement * Severe respiratory disease * Cognitive or psychiatric history that would make it difficult to assess pain score * Complex regional pain syndrome * Chronic pain condition such as fibromyalgia, neuropathic pain * Preoperative opioid use greater than the equivalent of morphine 50 mg PO daily * Allergy to any of the study drug * Coagulopathy

Design outcomes

Primary

MeasureTime frameDescription
Pain score on 11 point (0 - 10) numeric rating scaleFIrst 24 hour since the operationPostoperative pain score

Secondary

MeasureTime frameDescription
Local anesthetic consumption36 hours (or until block discontinuation)The total dose of local anesthetic used until the block is discontinued
Opioid consumption48 hours (or until discharge)The total amount of opioids consumed will be recorded until the patient is discharged
Side effectthrough to patient discharge, on average 48 hoursnausea, voting, pruritus
patient satisfactionthrough to patient discharge, on average 48 hours100 mm visual analogue scale
Block complicationthrough to patient discharge, on average 48 hourspersistent motor or sensory block, dyspnea, hoarseness, Horner syndrome

Countries

Canada

Contacts

Primary ContactBill Lin, FRCPC
cheng.lin@lhsc.on.ca+15196466000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026